Live feed
Filing
SC 13G/A
SC 13G/A0001929354-23-000004·Avalo Therapeutics, Inc.
Schedule 13G ownership disclosure
Avalo Therapeutics, Inc.
Security class unavailable · CUSIP: 05338F108
Event date: 2023-04-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,292,700
- Percent of class
- 9.8100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001929354-23-000004
- Form type
- SC 13G/A
- Filer
- Avalo Therapeutics, Inc.
- CIK
- CIK 1534120
- Filed
- Apr 19, 2023
- Reporting period
- Apr 18, 2023
- Description
- Schedule 13G beneficial ownership